Would it be possible to prevent HPA-1a alloimmunization to reduce the incidence of fetal and neonatal alloimmune thrombocytopenia?
Belinda M
BM
Kumpel
D016824:Antigens, Human Platelet / Q000276:immunology*; D001787:Blood Group Incompatibility / Q000276:immunology / Q000517:prevention & control*; D005260:Female; D005315:Fetal Diseases / Q000276:immunology / Q000517:prevention & control*; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D008431:Maternal-Fetal Exchange / Q000276:immunology*; D011247:Pregnancy; D054098:Thrombocytopenia, Neonatal Alloimmune / Q000276:immunology / Q000517:prevention & control*
D016824:Antigens, Human Platelet; C083451:human platelet antigen 1b